Total Payments
$12,679
2024 Payments
$1,217
Companies
37
Transactions
450
Medicare Patients
4,832
Medicare Billing
$228,133
Payment Breakdown by Category
Food & Beverage$10,264 (81.0%)
Travel$2,333 (18.4%)
Education$82.04 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,264 | 439 | 81.0% |
| Travel and Lodging | $2,333 | 7 | 18.4% |
| Education | $82.04 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $2,730 | 18 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $1,796 | 129 | $0 (2024) |
| ABIOMED | $1,453 | 26 | $0 (2023) |
| Abbott Laboratories | $969.37 | 11 | $0 (2019) |
| Amgen Inc. | $864.09 | 43 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $758.86 | 42 | $0 (2024) |
| PFIZER INC. | $720.63 | 55 | $0 (2024) |
| Edwards Lifesciences Corporation | $395.31 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $336.12 | 22 | $0 (2024) |
| Medtronic, Inc. | $315.61 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,217 | 56 | Novartis Pharmaceuticals Corporation ($351.68) |
| 2023 | $1,576 | 64 | Novartis Pharmaceuticals Corporation ($370.76) |
| 2022 | $923.22 | 32 | Amgen Inc. ($331.36) |
| 2021 | $701.85 | 35 | Janssen Pharmaceuticals, Inc ($286.51) |
| 2020 | $187.94 | 7 | ABIOMED ($170.81) |
| 2019 | $1,751 | 66 | ABIOMED ($399.06) |
| 2018 | $3,392 | 92 | Medtronic Vascular, Inc. ($1,987) |
| 2017 | $2,930 | 98 | Abbott Laboratories ($948.28) |
All Payment Transactions
450 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.76 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Genetic Disease | ||||||
| 10/29/2024 | Terumo Medical Corporation | ANGIO-SEAL (Device), METACROSS OTW | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: VASCULAR ACCESS | ||||||
| 10/23/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $30.14 | General |
| 10/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.74 | General |
| Category: Cardiovascular | ||||||
| 09/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Obesity | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $4.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: Cardiology | ||||||
| 09/04/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: Genetic Disease | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $34.46 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 08/23/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.20 | General |
| 08/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Cardiology | ||||||
| 08/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,172 | 1,451 | $213,567 | $55,475 |
| 2022 | 17 | 1,096 | 1,361 | $180,115 | $53,460 |
| 2021 | 17 | 1,205 | 1,461 | $203,022 | $57,715 |
| 2020 | 18 | 1,359 | 1,668 | $223,409 | $61,483 |
Total Patients
4,832
Total Services
5,941
Medicare Billing
$228,133
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 117 | 167 | $22,058 | $11,367 | 51.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 123 | $38,376 | $11,184 | 29.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 69 | 111 | $17,871 | $7,054 | 39.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 33 | 33 | $14,784 | $4,234 | 28.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 83 | 83 | $37,101 | $3,809 | 10.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 57 | 62 | $5,694 | $2,831 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 43 | $11,481 | $2,704 | 23.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 42 | 42 | $11,046 | $2,337 | 21.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 317 | 389 | $15,171 | $2,260 | 14.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,648 | $1,258 | 34.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 22 | 37 | $3,663 | $991.78 | 27.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 23 | 39 | $2,691 | $882.45 | 32.8% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 11 | 37 | $2,183 | $774.04 | 35.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 48 | 48 | $4,752 | $749.25 | 15.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $2,712 | $673.40 | 24.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 48 | 48 | $3,168 | $502.29 | 15.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 45 | 49 | $3,724 | $480.06 | 12.9% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 34 | 34 | $4,012 | $472.12 | 11.8% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 17 | 18 | $936.00 | $335.34 | 35.8% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 33 | 33 | $2,871 | $278.70 | 9.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 18 | 18 | $1,998 | $169.58 | 8.5% |
| 93922 | Ultrasound study of arm and leg arteries | Facility | 2023 | 13 | 13 | $3,627 | $130.39 | 3.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 146 | 227 | $28,828 | $16,863 | 58.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 82 | $23,938 | $6,527 | 27.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 59 | 108 | $16,524 | $6,009 | 36.4% |
About Dr. Robert Matheney, MD
Dr. Robert Matheney, MD is a Cardiovascular Disease healthcare provider based in Marrero, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356307177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Matheney, MD has received a total of $12,679 in payments from pharmaceutical and medical device companies, with $1,217 received in 2024. These payments were reported across 450 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($10,264).
As a Medicare-enrolled provider, Matheney has provided services to 4,832 Medicare beneficiaries, totaling 5,941 services with total Medicare billing of $228,133. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Marrero, LA
- Active Since 04/21/2006
- Last Updated 03/05/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1356307177
Products in Payments
- Impella (Device) $1,453
- ENTRESTO (Drug) $1,338
- XARELTO (Drug) $908.06
- PCI Optimization (Device) $759.85
- Repatha (Biological) $610.19
- ELIQUIS (Drug) $517.28
- LEQVIO (Drug) $457.47
- Claria MRI (Device) $454.29
- Corlanor (Drug) $243.90
- CHANTIX (Drug) $243.39
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $240.32
- ONPATTRO (Drug) $232.87
- Reveal LINQ (Device) $218.72
- BRILINTA (Drug) $208.63
- JARDIANCE (Drug) $160.60
- LINQ II (Device) $159.29
- RESOLUTE ONYX (Device) $156.32
- ICDs (Device) $149.04
- LifeVest (Device) $138.45
- Micra (Device) $135.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Marrero
Dr. Frederick Kushner, Md, MD
Cardiovascular Disease — Payments: $85,845
Cardiovascular Disease $85,845
Dr. Carlos Rodriguez Fierro, M.d, M.D
Cardiovascular Disease — Payments: $18,027
Cardiovascular Disease $18,027
Dr. Leslie Levenson, Md, MD
Cardiovascular Disease — Payments: $10,003
Cardiovascular Disease $10,003
Dr. Edmund Kerut, Md, MD
Cardiovascular Disease — Payments: $8,615
Cardiovascular Disease $8,615
Stephen Laguardia, Md, MD
Cardiovascular Disease — Payments: $7,756
Cardiovascular Disease $7,756
Dr. Brian Cospolich, Md, MD
Cardiovascular Disease — Payments: $7,654
Cardiovascular Disease $7,654